Patients with certain forms of systematic vasculitis, such as Wegener's granulomatosis, have circulating antineutrophil cytoplasmic antibodies (ANCA). These inappropriately stimulate circulating neutrophils adhere to and thereby obstruct small vessels. This, together with ANCA-induced degranulation and an oxidative burst, leads to local tissue damage. The signaling pathways that are activated by ANCA IgG are distinct from those that are involved in normal neutrophil activation. This study shows that diacylglycerol kinase is selectively activated by ANCA and that the generated phosphatidic acid is responsible for promoting neutrophil adhesion, in part through integrin activation. The data presented point to diacylglycerol kinase ␣ as a novel but selective target for the development of drugs to treat this potentially fatal disorder.
S
pecific forms of small-vessel systemic vasculitis (e.g., Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome) are associated with high levels of circulating antineutrophil cytoplasm autoantibodies (ANCA) during active phases of disease (1) . The two main types of these antibodies, those directed against proteinase 3 (PR3-ANCA) and myeloperoxidase (MPO-ANCA), can activate cytokine-primed neutrophils, inducing an oxidative burst, degranulation, production of IL-8, and changes in the actin cytoskeleton that may result in shape change and adhesion to vessels. These effects can result in retention of activated neutrophils in small vessels, in particular in the lung and the kidney, which can lead to both vascular obstruction and local damage as a result of the release from the neutrophils of proteolytic enzymes and reactive oxygen species (2) .
The signaling pathways that are activated by ANCA and lead to leukocyte activation have been the subject of much investigation, although the mechanisms involved remain incompletely defined. Identification of unique pathways would be of great importance because this could point to sites of potential therapeutic intervention for this poorly responsive and often fatal condition, which currently requires use of nonspecific immune-suppressing regimes to induce remission. Our previous studies demonstrated that ANCA uses signaling pathways in a manner that is distinct from conventional neutrophil activation involving Fc␥ R ligation. Cytokine-primed neutrophils express the ANCA antigens PR3 and MPO on the cell surface. The autoantibody ligates these antigens using F(abЈ) 2 portions of the ANCA IgG and co-ligates the neutrophil Fc␥R receptors using Fc portions of ANCA IgG, with apparently both Fc␥ RIIa and Fc␥ RIIIb receptors being activated (3) (4) (5) . The binding of ANCA antigens and Fc␥R receptors stimulates two distinct signaling cascades, one tyrosine kinase mediated activating Syk, cbl, and probably phospholipase C␥, and the second activating the heterotrimeric G protein Gi to stimulate phosphatidylinositol-3 kinase (PI-3K) type 1␥, protein kinase B, and p21 ras ; both pathways are required for superoxide generation (3) (4) (5) . These studies generated the surprising finding that, in contrast to conventional Fc␥ R ligation, ANCA did not activate phospholipase D (PLD) or activate type 1␣, ␤, or ␦PI-3K (3) . Because a number of recent studies have implicated PLD and its product phosphatidic acid (PtdOH) in both superoxide generation and cytoskeletal change (6, 7) , this result was unexpected. Therefore, we specifically examined PtdOH generation in ANCA-stimulated neutrophils and report here that there is indeed elevation of PtdOH, which is involved in cytoskeletal change and particularly in adhesion of the neutrophils, but that this is generated by activation of a diacylglycerol kinase (DG kinase). Because inhibition of this pathway of PtdOH formation inhibited adhesion of ANCA-stimulated neutrophils, this work suggests that inhibition of DG kinase may be a suitable target for effective therapeutic intervention in vasculitis.
Materials and Methods

IgG Isolation
Plasma samples from which serum was derived by defibrination were obtained from three PR3-ANCA-and three MPO-ANCA IgGpositive patients and three healthy volunteers. All patients fulfilled Chapel Hill definitions, and all had active disease because plasma was obtained from discarded plasmapheresis samples. IgG was isolated by selection on protein G-Sepharose columns and eluted with 0.1 M glycine (pH 2.7). Protein concentrations were determined by spectrophotometry. We have never detected differences in signaling responses between anti-PR3 and anti-MPO antibodies; therefore, we have not distinguished between the different ANCA. F(abЈ) 2 fragments were generated from IgG by overnight digestion with pepsin. In addition, a mouse/human chimeric anti-PR3 antibody that was generated in house was used to compare a monoclonal response with patient polyclonal ANCA (data not shown).
Neutrophil Isolation
Blood was obtained from healthy volunteers, and neutrophils were isolated by centrifugation over a Percoll discontinuous gradient as described previously (2) . Viability was measured by the ability of the cells to exclude Trypan blue. More than six donors were used for functional experiments to control for any effects that might result from variation in surface expression of PR3, Fc receptor polymorphisms, or other polymorphic inheritances that might affect the results.
Inhibition of DG Kinase Activity
R59022 (Calbiochem, La Jolla, CA) was dissolved in DMSO. The stock solution was diluted in HBSS that contained 10 mM HEPES (pH 7.4; HBH) before use, and neutrophils were preincubated for 10 min with R59022 before priming. Viability was assessed by Trypan blue exclusion. DMSO was also diluted and used as vehicle control at the highest concentration.
Lipid Extraction and Analysis
Neutrophils were pelleted by centrifugation, and lipids were extracted after the addition of 500 ng of 12:0/12:0-PA (internal standard). Organic phases were resuspended in 25 l of chloroform/methanol/ water (5:5:1). Gradient separation of phospholipids (1-l injections) was performed on a Luna silica2 column (3 m, 1.0 ϫ 150 mm; Phenomenex, Macclesfield, UK) using 100% chloroform/methanol/water (90: 9.5:0.5 by vol) that contained 7.5 mM ethylamine (Solvent A) changing to 20% acetonitrile/chloroform/methanol/water (30:30:32:8 by vol) that contained 10 mM ethylamine (Solvent B) over 1 min then to 35% Solvent B over 9.5 min then to 70% Solvent B over 9.5 min at 100 l/min before recycling back to Solvent A over 1 min at 140 l/min and held for 14 min to re-equilibrate. Detection of the lipids was by negative electrospray ionization on a Shimadzu QP8000␣ single quadrupole MS (probe voltage Ϫ4 kV; nebulizer gas 4l/min N 2 ; curved desolvation line temperature 300°C; Milton Keynes, UK).
Superoxide Assay
Superoxide production was measured by the superoxide dismutase inhibitable reduction of ferricytochrome C as described previously (3) . Neutrophils were resuspended in HBH at a concentration of 2 ϫ 10 6 cells/ml and primed with 2 ng/ml TNF-␣ and 5 g/ml cytochalasin B for 15 min at 37°C. Aliquots of 10 5 cells were stimulated with 200 g/ml IgG, and superoxide release was measured over 120 min. All samples were tested in triplicate, and experiments were repeated six times with various neutrophil and IgG combinations.
Adhesion Assay
Maxisorp 96-well plates (Nunc, Fisher Scientific UK, Loughborough, UK) were coated with 25 g/ml fibrinogen in 20 mM NaH 2 PO 4 (pH 8.0) and 150 mM NaCl overnight at 37°C. Wells were washed with PBS and blocked with HBH that contained 0.1% heat-inactivated BSA for 1 h at 37°C. Neutrophils were resuspended at 5 ϫ 10 6 cells/ml in HBH and primed with 2 ng/ml TNF-␣ for 15 min. Aliquots of 5 ϫ 10 5 cells were added to wells and stimulated with 400 g/ml IgG for 120 min. Nonadherent cells were removed by washing with HBH, and adherent cells were fixed with 1% glutaraldehyde for 15 min and stained with 0.1% crystal violet for 10 min. Cells were solubilized with 1% Triton-X 100 and the optical density measured at 550 nm.
FACS Measurement of the Active Conformation of CD11b
Neutrophils were suspended at 1 ϫ 10 6 /ml in PBS/BSA. Neutrophil suspension (100 l) was added to 5 l of FITC-conjugated mouse IgG1 isotype control antibody (Dakocytomation, Glostrup, Denmark) or FITC-conjugated anti-CD11b activation epitope antibody CBRM1/5 (eBioscience, San Diego, CA) along with the relevant treatment, which included vehicle or R59022 for 10 min, 2 ng/ml TNF-␣ for 15 min, and then normal human IgG (250 g/ml) or ANCA IgG (250 g/ml) for 20 to 60 min. Neutrophils were fixed in 2% paraformaldehyde and washed with cold HBH. Fluorescence was measured as described.
Western Blotting
Neutrophils (5 ϫ 10 6 ) were incubated with 5 M LY294002, primed with 2 ng/ml TNF-␣, and stimulated with 250 g of ANCA or 25 g of anti-PR3 antibody for 15 min. Total cell protein was resolved by 8% SDS-PAGE. Western blotting using anti-phospho-protein kinase B (PKB) 1:1000 (New England Biolabs, Hitchin, UK) followed by stripping and reprobing using anti-PKB (New England Biolabs) was performed as described previously (5). The presence of DG kinase ␣ was detected by blotting with a monoclonal anti-DG kinase ␣, a gift from Dr. W. van Blitterswijk (Netherlands Cancer Institute, Amsterdam, Netherlands) (8).
Statistical Analyses
All experiments were repeated at least three times with a minimum of three replicate samples. Results are presented as means Ϯ SEM, and Mann-Whitney test was used to determine significance where appropriate.
Results
ANCA IgG Elevates Phosphatidic Acid Production in Neutrophils
To determine unambiguously the changes in neutrophil PtdOH, we analyzed the lipid by HPLC-coupled mass spectrometry. Cells contain multiple species of PtdOH; however, we previously demonstrated that the predominant signaling forms are those with monounsaturated or diunsaturated structures (9). The fully saturated or more unsaturated forms are poor signals and are probably intermediates in metabolic pathways or, in the case of polyunsaturated PtdOH, produced by the cell as it removes the polyunsaturated DG species, which are the forms that activate protein kinase C (PKC) in an intact cell (10) . Treatment of neutrophils with normal IgG for 15 min induced a small increase in PtdOH, primarily 18:0/18:1 species ( Figure  1 ), as would be expected; because this ligand induces PLD activity, there was little change in other PtdOH species, which are not shown for the sake of clarity. This PtdOH species is not generated as a result of phospholipase C-catalyzed phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P 2 ] hydrolysis because polyphosphoinositides are primarily polyunsaturated lipids (generally 18:0/20:4) (9). Surprising, ANCA IgG also elevated the cellular level of 18:0/18:1 PtdOH to a higher level than that induced by normal IgG. In some preparations of neutrophils, ANCA IgG stimulated an increase in PtdOH within 5 min that was sustained for 20 min, whereas in others, an increase was apparent only after 7 min, which peaked at 15 min, but PtdOH levels then declined back toward basal by 20 min (see Figure 1B ). These differences were seen with both PR3-ANCA and MPO-ANCA and so were not aligned with ANCA specificity. The reasons for the variation are unclear, but the cellular level of PtdOH is a balance between generation and removal and may reflect differences between the cell populations. Identical data were achieved when neutrophils were stimulated with ANCA IgG F(ab) 2 fragments ( Figure 1B ). Because we previously demonstrated that ANCA IgG does not stimulate PLD activity, we reasoned that the elevated PtdOH could be generated by a DG kinase activity; therefore, we stimulated cells with ANCA IgG after preincubation with 18 M R59022, a potent DG kinase inhibitor (11) . Figure 1A shows that the ANCA-stimulated generation of PtdOH was completely attenuated by R59022. Although inhibition was observed at lower R59022 concentrations, attempts to generate a clear dosage dependence of inhibition were unsuccessful. This was probably because the activity of lipid phosphate phosphatases, which remove PtdOH in cells, is regulated solely by substrate availability; therefore, the lipid messenger is rapidly removed after generation, preventing clear dosage responses from being obtained. The inhibition of PtdOH generation was not a nonspecific effect of R59022 on the ability of ANCA IgG to bind to neutrophils because there was no effect on the surface expression of the ANCA antigens PR3 or MPO in either control or TNF-␣-treated cells, and identical data were obtained when ANCA IgG F(ab) 2 fragments were used to stimulate the neutrophils (data not shown). R59022 is highly selective for the ␣ form of DG kinase; immunoblotting of neutrophil extracts with a specific anti-DG kinase ␣ antibody confirmed expression of this isoform ( Figure 1C ).
ANCA IgG-Stimulated DG Kinase Activity Promotes Neutrophil Adhesion
The relevance of DG kinase inhibition for ANCA-stimulated neutrophil responses was addressed by examination of superoxide formation ( Figure 2 ) and adhesion to fibrinogen ( Figure  3 ). The R59022 suppressed ANCA-stimulated superoxide generation when it was used at concentrations of 42.7 M or greater; however, at these high concentrations, there was significant loss in cell viability. Indeed, the loss in cell viability was mirrored by the inhibition of superoxide generation (Figure 2) . Therefore, it is unlikely that ANCA-stimulated superoxide generation is mediated by DG kinase-activated PtdOH formation. Both PR3-and MPO-ANCA IgG stimulated the adhesion of approximately three-fold more neutrophils to a fibrinogen surface than a control normal IgG. At R59022 concentrations Ͼ18 M, this increase was prevented, and the number of cells that adhered to the surface was the same as that observed with normal IgG ligation (Figure 3 ): Significantly the inhibition was observed at R59022 concentrations that did not affect cell viability (compare Figures 2 and 3) . The adhesion of neutrophils is in part mediated by activation of the CD11b/CD18 integrin. Figure 4 shows that both priming neutrophils with TNF-␣ and subsequently stimulating them with ANCA IgG increased the active conformation of the integrin; again, this increase was greater than with normal IgG. Addition of R59022 significantly suppressed, although not completely, the increase in CD11b/ CD18 activation that was brought about by ANCA IgG while having no effect on the TNF-␣-stimulated increase (Figure 4 ). This effect of ANCA-stimulated PtdOH generation on the integrin is an effect on activation, because we previously demonstrated that ANCA does not effect overall surface expression of CD18 (12) .
Although these data suggest that DG kinase activity is important for ANCA-stimulated adhesion, they do not identify the mechanism; therefore, we made use of short-chain lipid addition to cells to mimic stimulated changes and overcome inhibitory effects. We previously demonstrated that these short-chain lipids (di:8:0) can cross the plasma membrane and bring about effects on cells (13) . In the absence of ANCA IgG, neither short-chain PtdOH nor short-chain DG stimulated adhesion; neither did short-chain PtdOH inhibit ANCA-stimulated adhesion ( Figure 5 ). Indeed, in some experiments, the lipid potentiated ANCA-stimulated adhesion. R59022-suppressed ANCA-induced adhesion was reversed by the addition of 3.125 M short-chain PtdOH but not by lower concentrations; reversal was not achieved by the addition of 3.1 M short-chain DG. Therefore ANCA-induced, DG kinase-catalyzed PtdOH formation is necessary for ANCA-induced neutrophil adhesion.
Signaling Pathways that Mediate ANCA-Stimulated DG Kinase Activity
We previously showed that ANCA IgG stimulates both tyrosine kinase and Gi-mediated signaling in neutrophils (4, 5) . Therefore, we tested whether inhibition of these pathways would prevent adhesion. Addition of pertussis toxin to neutro- phils 2 h before stimulation of ADP-ribosylates Gi and Go proteins prevents their dissociation into ␣ and ␤␥ subunits and thereby inhibits their signaling (5). Figure 6 shows that pertussis toxin inhibits but does not completely ablate ANCA-stimulated adhesion; this was reversed by PtdOH but not DAG addition. Addition of 4-amino-1-tert-butyl-3-(1Ј-naphthyl)pyrazolo[3,4-d]pyrimidine (PP1), which ablates tyrosine kinase signaling through the Syk pathway in neutrophils (4), also inhibited ANCA-stimulated adhesion, although, in this case, the inhibition was more complete. Addition of 3.125 M PtdOH to the PP1-treated neutrophils increased adhesion, although the effect was small and significant only at the P ϭ 0.2 level ( Figure  6 ). This demonstrates that a number of tyrosine kinase-dependent pathways regulate changes in the actin cytoskeleton in neutrophils in addition to DG kinase.
These results suggested that the ANCA-stimulated DG kinase activation that promoted adhesion was mediated primarily through the Gi pathway. ANCA-stimulated Gi-mediated signaling is activated after binding of ANCA IgG F(abЈ) 2 to surface antigens; in keeping with this proposed pathway, the ANCA IgG F(abЈ) 2 fragments also induced PtdOH formation (see Figure 1B) . ANCA IgG F(abЈ) 2 fragments were also able to induce adhesion of neutrophils, although not to the same level as intact antibodies ( Figure 7) ; this is not surprising because the fragments only activate some of ANCA-stimulated signaling events, others of which will additionally contribute to the magnitude of processes such as adhesion. R59022 is reported to function primarily as an inhibitor of DG kinase ␣ (14); therefore, we considered which signaling pathways could be involved in mediating its activation. It has been reported that Src and similar kinases can activate DG kinase ␣; however, we were able only partially to reverse PP1-induced inhibition of ANCAstimulated adhesion with the short-chain, cell-permeant PtdOH ( Figure 6B ). This points to effects of the inhibitor above the inhibition of DG kinase activity. It has been suggested that in an ill-defined manner, PtdIns-3-kinase can stimulate DG kinase ␣ (15); therefore, we determined whether the PtdIns-3-kinase inhibitor LY294002 could affect ANCA-induced signaling. Figure  8A shows that LY294002 inhibited ANCA-stimulated PtdOH formation in a manner similar to R59022; however, whereas LY294002 was able to inhibit ANCA-stimulated PKB phosphorylation, incubation with R59022 had only a small effect ( Figure  8B ). In addition, whereas short-chain PtdOH was able to reverse the inhibitory effect of R59022 on ANCA-stimulated adhesion, it was unable to reverse the inhibition that was brought about by LY294002 ( Figure 8C ). This points to the additional roles played by PtdIns-3-kinase signaling in regulating changes in the neutrophil actin cytoskeleton, such as control of the activity of the Rho family of GTPases (16) . . ANCA IgG F(abЈ) 2 fragments stimulate the adhesion of neutrophils. TNF-␣-primed neutrophils were allowed to adhere for 2 h to fibrinogen-coated 96-well plates in the presence of control, normal IgG F(abЈ) 2 fragments, ANCA, or ANCA IgG F(abЈ) 2 fragments. Adhesion that was induced by ANCA F(abЈ) 2 fragments was significantly different from both control and normal F(abЈ) 2 fragments (*P ϭ 0.017 and 0.047, respectively). The adhesion that was induced by normal F(abЈ) 2 fragments was not significantly different from control (P ϭ 0.17). Data are from at least six different neutrophil donor and ANCA combinations.
Discussion
ANCA IgG activation of neutrophils stimulates superoxide generation, degranulation and, cell adhesion. These events are central to the pathologic effects of ANCA; therefore, characterizing the signaling that is involved in these pathways may point to novel therapeutic sites. Clearly, for a signaling pathway to be considered as a therapeutic target, it must be excessively or uniquely activated in the disease state. Stimulation of neutrophils by fMLP or by normal IgG is capable of promoting their adhesion and superoxide formation. We demonstrated previously, however, that the signaling pathways that are activated by these agents are distinct from those that are stimulated by activation of neutrophils by ANCA IgG despite generating the same physiologic effects (3, 5) . This suggested that selective intervention in ANCA-mediated signaling has the potential to be of therapeutic use in the treatment of vasculitis. In this article, we have extended our previous studies to demonstrate the selective activation within the human neutrophil of a Gi-and PtdIns-3-kinase-mediated DG kinase activity that produces PtdOH; this in turn activates integrin-mediated neutrophil adhesion. Therefore, the data presented in this article strongly point to DG kinase's being a selective target for therapeutic intervention.
The mechanism of PtdOH-stimulated adhesion is likely to be similar to what we previously demonstrated for the RBL-2H3 mast cell line in which the lipid-stimulated PtdIns(4)phosphate-5-kinase I␥ activity produces an increase in membrane PtdIns(4,5)P 2 , which then activates the integrin through interaction with talin (13) . This work is distinct and novel because in mast cells and, indeed, in fMLP-stimulated neutrophils, in contrast to ANCA IgG stimulation, the PtdOH is generated through a PLD-catalyzed pathway. This suggested role for PtdOH in ANCA-stimulated integrin activation is supported by the data in Figure 4 showing that inhibition of DG kinase activity reduced the exposure and thereby the active conformation of CD11b/CD18 on ANCA-stimulated neutrophils. The incomplete effect of the inhibitor points to additional means of activating integrins.
The physiologic role of DG kinase was initially thought to be a pathway solely for removing the activator of PKC, DG (17) . However, it is apparent that the PtdOH that is generated by this reaction can have a signaling role, and a number of studies have pointed to important roles for this pathway, with PtdOH able to activate a number of enzymes in signaling cascades such as phosphatidylinositol 4-phosphate 5-kinase (18) , cAMP phosphodiesterase 4A1 (19) , and sphingosine kinase (20) . The DG kinases are a multigene family of enzymes that are subdivided into five classes with differing regulation and apparent regulatory functions (17) . Part of the basis of these differences relates to distinct intracellular localizations, although in different contexts, the same enzyme can be found on different intracellular membranes; for instance, we previously reported a role for DG kinase ␣ in the nucleus of IL-2-stimulated mouse T lymphocytes (21) , whereas activation of the T cell antigen receptor induced translocation of the enzyme to the plasma membrane (22) , a pathway analogous to that reported in this work.
In contrast to the lack of effect on ANCA-stimulated superoxide generation at relevant concentrations (Figure 2) , R59022 has been shown to potentiate fMLP-stimulated superoxide anion formation (23, 24) , in a PKC activity-dependent manner. We previously demonstrated that the activation of PKC in intact cells requires polyunsaturated DG species (25) ; however, ANCA-stimulated DG kinase activity phosphorylates monounsaturated DG species (Figure 1) , which are without effect on PKC activation (9) . Therefore, the distinction between fMLPand ANCA-stimulated superoxide generation is due to the involvement of separate lipid signaling pathways.
ANCA-stimulated signaling in neutrophils involves activation of Fc␥ RIIa and RIIIb as well as F(abЈ) 2 binding to MPO or PR3 with accompanying stimulation of Gi-mediated signaling. Although the two ANCA antigens have different functional activities, that they both are cationic may be the reason for their activation of the same intracellular signaling pathway. We previously demonstrated that signaling through the two "arms" is necessary for ANCA-stimulated adhesion of neutrophils and superoxide generation, and it is apparent that both are involved in ANCA-activated DG kinase. Although we are not able to prove definitively because of a lack of suitable antibodies, it is most likely that the isoform that is involved in the signaling is DG kinase ␣. The basis of this conclusion is (1) confirmation of the presence of this isoform in neutrophils by PCR analysis (26) and by Western blotting ( Figure 1C) ; (2) that R59022 is highly selective for the ␣ isoform (14) ; and (3) that the reported signaling regulation of this isoform is in keeping with that detected in the ANCA-stimulated cells (17) .
DG kinase ␣ is a type I enzyme that is characterized by two C1 domains that do not bind DAG and are structurally distinct from those in PKC and therefore may play a different regulatory role, a conserved kinase domain and two Ca 2ϩ -binding EF hands (17) . DG kinase ␣ is also phosphorylated by some PKC isoforms but more pertinently by Src family kinases (23) . These characteristics point to the mechanism of regulation by ANCA. Activation of Fc␥ stimulates Src family kinases to phosphorylate and thus activate phospholipase C␥ (PLC␥) catalyzing phosphatidylinositol 4,5-bisphosphate hydrolysis, inositol 1,4,5-trisphosphate formation and thus an elevation in intracellular free [Ca 2ϩ ] activates DG kinase ␣via the EF hands (27) . The Src kinase also phosphorylates and activates DG kinase ␣ directly (28) . Activation of the Gi ␤␥ subunit-regulated PI-3K I␥ generates 3-phosphorylated lipid products that can also activate DG kinase ␣ (15). Therefore, the three pathways that previously were shown to be critical for ANCA-mediated signaling-Src, PLC␥, and PI-3K-cooperate to activate DG kinase ␣ and thereby stimulate adhesion through coordinated activation of this lipid kinase. In addition, studies in epithelial cells suggested that DG kinase, PtdIns(4)phosphate-5-kinase, Rac, and RhoGDI exist in a signaling complex (29); a similar complex in neutrophils, including an input from PtdIns-3-kinase, could explain the coordination of the ANCA-activated signaling that leads to adhesion. Figure 9 summarizes our proposed signaling cascades that are activated by ANCA in human neutrophils.
The importance of DG kinase in neutrophil function is emphasized by the study of Gronert et al. (26) , who detected reduced expression but not absence of DG kinase ␣ in neutrophils from patients with localized aggressive periodontitis, in whom neutrophil chemotaxis is compromised. The importance of PtdOH in the activation of CD11b/CD18 in human eosinophils has been documented (30) , and its relevance in human neutrophils is demonstrated here, although inhibition of ANCA-stimulated DG kinase activity did not completely prevent ANCA-stimulated activation of CD11b/CD18. This observation is important in that complete inhibition or absence of ␤ 2 integrins ablates ANCA-stimulated superoxide generation (4, 31) , and although we observed an extensive effect on ANCAstimulated adhesion by the DG kinase inhibitor, there was only a small effect on superoxide generation. In addition, both PR3 (32) and MPO (33) have been shown to co-localize with CD18.
The data presented in this article point to DG kinase ␣ as a selective target for treatment of patients with vasculitis because it may be possible thereby to prevent ANCA-stimulated adhesion of the neutrophils while not affecting other aspects of normal neutrophil function. Therefore, it may be possible to treat patients with compounds that will not have the general immunosuppressive effects of current therapies; this could lead to better patient care for acute active disease.
